Intelligent ventilation in the intensive care unit
Objectives. Automated, microprocessor-controlled, closed-loop mechanical ventilation has been used in our Medical Intensive Care Unit (MICU) at the Hadassah Hebrew-University Medical Center for the past 15 years; for 10 years it has been the primary (preferred) ventilator modality. Design and se...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
South African Medical Association
2012-08-01
|
| Series: | Southern African Journal of Critical Care |
| Online Access: | http://www.sajcc.org.za/index.php/sajcc/article/download/130/141 |
| _version_ | 1797331875274948608 |
|---|---|
| author | Sigal Sviri Abed Bayya Phillip Levin Rabia Khalaila Ilana Stav David Linton |
| author_facet | Sigal Sviri Abed Bayya Phillip Levin Rabia Khalaila Ilana Stav David Linton |
| author_sort | Sigal Sviri |
| collection | DOAJ |
| description | Objectives. Automated, microprocessor-controlled, closed-loop mechanical ventilation has been used in our Medical Intensive Care Unit (MICU) at the Hadassah Hebrew-University Medical Center for the past 15 years; for 10 years it has been the primary (preferred) ventilator modality.
Design and setting. We describe our clinical experience with adaptive support ventilation (ASV) over a 6-year period, during which time ASV-enabled ventilators became more readily available and were used as the primary (preferred) ventilators for all patients admitted to the MICU.
Results. During the study period, 1 220 patients were ventilated in the MICU. Most patients (84%) were ventilated with ASV on admission. The median duration of ventilation with ASV was 6 days. The weaning success rate was 81%, and tracheostomy was required in 13%. Sixty-eight patients (6%) with severe hypoxia and high inspiratory pressures were placed on pressure-controlled ventilation, in most cases to satisfy a technical requirement for precise and conservative administration of inhaled nitric oxide.
The overall pneumothorax rate was less than 3%, and less than 1% of patients who were ventilated only using ASV developed pneumothorax.
Conclusions. ASV is a safe and acceptable mode of ventilation for complicated medical patients, with a lower than usual ventilation complication rate. |
| first_indexed | 2024-03-08T07:41:37Z |
| format | Article |
| id | doaj.art-0918bc3ce77443fe8607847e7de0df8d |
| institution | Directory Open Access Journal |
| issn | 1562-8264 2078-676X |
| language | English |
| last_indexed | 2024-03-08T07:41:37Z |
| publishDate | 2012-08-01 |
| publisher | South African Medical Association |
| record_format | Article |
| series | Southern African Journal of Critical Care |
| spelling | doaj.art-0918bc3ce77443fe8607847e7de0df8d2024-02-02T17:10:55ZengSouth African Medical AssociationSouthern African Journal of Critical Care1562-82642078-676X2012-08-0128161410.7196/SAJCC.130Intelligent ventilation in the intensive care unitSigal SviriAbed BayyaPhillip LevinRabia KhalailaIlana StavDavid LintonObjectives. Automated, microprocessor-controlled, closed-loop mechanical ventilation has been used in our Medical Intensive Care Unit (MICU) at the Hadassah Hebrew-University Medical Center for the past 15 years; for 10 years it has been the primary (preferred) ventilator modality. Design and setting. We describe our clinical experience with adaptive support ventilation (ASV) over a 6-year period, during which time ASV-enabled ventilators became more readily available and were used as the primary (preferred) ventilators for all patients admitted to the MICU. Results. During the study period, 1 220 patients were ventilated in the MICU. Most patients (84%) were ventilated with ASV on admission. The median duration of ventilation with ASV was 6 days. The weaning success rate was 81%, and tracheostomy was required in 13%. Sixty-eight patients (6%) with severe hypoxia and high inspiratory pressures were placed on pressure-controlled ventilation, in most cases to satisfy a technical requirement for precise and conservative administration of inhaled nitric oxide. The overall pneumothorax rate was less than 3%, and less than 1% of patients who were ventilated only using ASV developed pneumothorax. Conclusions. ASV is a safe and acceptable mode of ventilation for complicated medical patients, with a lower than usual ventilation complication rate.http://www.sajcc.org.za/index.php/sajcc/article/download/130/141 |
| spellingShingle | Sigal Sviri Abed Bayya Phillip Levin Rabia Khalaila Ilana Stav David Linton Intelligent ventilation in the intensive care unit Southern African Journal of Critical Care |
| title | Intelligent ventilation in the intensive care unit |
| title_full | Intelligent ventilation in the intensive care unit |
| title_fullStr | Intelligent ventilation in the intensive care unit |
| title_full_unstemmed | Intelligent ventilation in the intensive care unit |
| title_short | Intelligent ventilation in the intensive care unit |
| title_sort | intelligent ventilation in the intensive care unit |
| url | http://www.sajcc.org.za/index.php/sajcc/article/download/130/141 |
| work_keys_str_mv | AT sigalsviri intelligentventilationintheintensivecareunit AT abedbayya intelligentventilationintheintensivecareunit AT philliplevin intelligentventilationintheintensivecareunit AT rabiakhalaila intelligentventilationintheintensivecareunit AT ilanastav intelligentventilationintheintensivecareunit AT davidlinton intelligentventilationintheintensivecareunit |